Paying users zone. Data is hidden behind: .
Get 1-month access to Bristol-Myers Squibb Co. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Adjustments to Financial Statements
Advanced level
Adjustments to Current Assets
Bristol-Myers Squibb Co., adjusted current assets
US$ in millions
| Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| Current assets | ||||||
| Adjustments | ||||||
| Add: Bad debt allowances | ||||||
| After Adjustment | ||||||
| Adjusted current assets | ||||||
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
Adjustments to Total Assets
Bristol-Myers Squibb Co., adjusted total assets
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »
2 Deferred income tax assets, non-current. See details »
Adjustments to Current Liabilities
Bristol-Myers Squibb Co., adjusted current liabilities
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »
Adjustments to Total Liabilities
Bristol-Myers Squibb Co., adjusted total liabilities
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Deferred income tax liabilities, current (included in Liabilities related to assets held-for-sale). See details »
3 Deferred income tax liabilities, non-current. See details »
Adjustments to Stockholders’ Equity
Bristol-Myers Squibb Co., adjusted total Bristol-Myers Squibb Company shareholders’ equity
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Deferred tax assets (liabilities), net. See details »
Adjustments to Capitalization Table
Bristol-Myers Squibb Co., adjusted capitalization table
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Current operating lease liabilities. See details »
3 Non-current operating lease liabilities. See details »
4 Deferred tax assets (liabilities), net. See details »
Adjustments to Reported Income
Bristol-Myers Squibb Co., adjusted net earnings attributable to BMS
US$ in millions
Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).
1 Deferred income tax expense (benefit). See details »